:efgartigimod:

Qianqian Zhang1, Wenping Yang1, Yun Qian1

  • 1Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China.

Frontiers in immunology
|October 18, 2024
PubMed
概括

埃夫加蒂格莫德可为具有抗NMDAR,抗LGI1或抗GABABR抗体的自身免疫脑炎 (AE) 患者提供快速症状缓解. 本案例报告强调了其作为这些具有挑战性的神经疾病有效治疗的潜力.